Table 6. Comparison between patients who survived with who did not in the follow-up period.
| Characteristics | Follow-up survivals (n=529) | Follow-up death (n=40) | P value |
|---|---|---|---|
| Hypertension (%) | 350 (66.2) | 33 (82.5) | 0.034 |
| Regular treatment of hypertension (%) | 182 (34.4) | 5 (12.5) | 0.004 |
| Antihypertensive medications | |||
| Beta-blocker (%) | 132 (25.0) | 5 (12.5) | 0.076 |
| Calcium channel blocker (%) | 102 (19.3) | 4 (10.0) | 0.146 |
| Diuretic (%) | 58 (11.0) | 1 (2.5) | 0.108 |
| ACEI or ARB (%) | 74 (14.0) | 3 (7.5) | 0.247 |
| Others (%) | 50 (9.5) | 7 (17.5) | 0.105 |
| Uncontrolled hypertension (%) | 157 (29.7) | 15 (37.5) | 0.299 |
Data presented as n (%). ACEI, angiotensin-converting enzyme inhibitors; ARB, angiotensin receptor blocker.